Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Inspired Entertainment, Inc (INSE) reported Q4 2025 gaap earnings of -$0.18 per share, missing the $0.21 consensus estimate (miss by 186.9%). The company g...
The post Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates first appeared on Alphastreet.
Dianthus Therapeutics posts wider-than-expected Q4 loss of $1.43/share on collapsing revenue, yet shares surge 21.5% on pipeline optimism.
The post DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally first appeared on Alphastreet.
**SuRo Capital Corp Reports Wider-Than-Expected Q4 Loss**
The post SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% first appeared on Alphastreet.
**Tenax Therapeutics Reports Q4 2025 Results**
The post Tenax Therapeutics Inc (TENX) Reports Q4 Earnings first appeared on Alphastreet.
Bloom Energy posts GAAP EPS beat at $0.45 vs $0.30 estimate, but adjusted EPS of -$0.30 and weak Q1 guidance spark profitability concerns despite 12% stock surge.
The post Bloom Energy (BE) Surges 12% Despite Adjusted Loss of $0.30 Per Share, Weak Q1 Outlook first appeared on Alphastreet.
Legend Biotech Corporation (LEGN) reported Q4 2025 adjusted earnings of $0.01 per share. No consensus estimate was available for comparison. Top-line reven...
The post Legend Biotech Corporation (LEGN) Reports Q4 Earnings first appeared on Alphastreet.
SCI President forfeited 3,300 shares at $81.42 for tax obligations, part of a four-executive cluster totaling $675,053 in routine equity compensation withholdings.
The post SCI President Forfeits 3,300 Shares at $81.42 in Tax Withholding Transaction first appeared on Alphastreet.
URBN executives forfeited 30,862 shares worth $2.03M for tax withholding on March 9, led by Global CEO Sheila Harrington's 3,959-share surrender at $65.62.
The post URBN Insiders Surrender Over 30K Shares Valued at $2M for Tax Obligations as Stock Trades at $65.62 first appeared on Alphastreet.
Gregory T. Lucier purchased 15,000 shares at $12.445, deploying $186,675 to increase his stake by 30% to 65,000 shares.
The post DENTSPLY SIRONA (XRAY) Insider Gregory T. Lucier Buys 15,000 Shares at $12.45, Boosting Stake 30% first appeared on Alphastreet.
Kohl's Corporation (NYQ:KSS), the omnichannel retailer operating department stores across the United States, reported fourth quarter 2025 results that exce...
The post KSS (KSS) Beats Q4 EPS Estimates by a Wide Margin first appeared on Alphastreet.
**BREAKING: Esperion Therapeutics Reports Q4 2025 Results**
The post Esperion Therapeutics, Inc (ESPR) Reports Q4 Earnings first appeared on Alphastreet.
TTMI posts Q4 EPS of $0.70 vs $0.68 estimate, revenue reaches $774.3M as shares jump 10.1% on fourth straight earnings beat.
The post TTMI Shares Surge 10.1% After Beating Q4 Earnings Estimates for Fourth Consecutive Quarter first appeared on Alphastreet.
Willis Lease Finance Corporation (WLFC) reported Q4 2025 gaap earnings of $2.81 per share. No consensus estimate was available for comparison. The company ...
The post Willis Lease Finance Corporation (WLFC) Reports Q4 Earnings first appeared on Alphastreet.
ABM Industries Inc (ABM) reported Q1 2026 gaap earnings of $0.83 per share, missing the $0.87 consensus estimate (miss by 4.8%). Revenue came in at $18.43B...
The post ABM Industries Inc (ABM) Misses Q1 EPS Estimates first appeared on Alphastreet.
Legend Biotech posts $0.01 adjusted EPS in Q4 2025, turning profitable on 64% revenue growth to $306.3M as commercial momentum builds.
The post Legend Biotech (LEGN) Turns Profitable With $0.01 EPS on 64% Revenue Surge to $306.3M in Q4 first appeared on Alphastreet.
**BREAKING: Apyx Medical Corporation Reports Q4 2025 Results**
The post Apyx Medical Corporation (APYX) Reports Q4 Earnings first appeared on Alphastreet.
**BioNTech SE Reports Q4 2025 Results**
The post BioNTech SE (BNTX) Reports Q4 Earnings first appeared on Alphastreet.
BioNTech reports Q4 loss of $0.33/share on revenue of $907.4M, down 23.8% year-over-year as vaccine demand normalizes.
The post BioNTech (BNTX) Posts Q4 Loss of $-1.25/Share as Revenue Falls 23.8% YoY to $907.4M first appeared on Alphastreet.
Q32 Bio Inc. (QTTB) reported Q4 2025 adjusted earnings of $3.65 per share. No consensus estimate was available for comparison. Top-line revenue was $53.7M.
The post Q32 Bio Inc. (QTTB) Reports Q4 Earnings first appeared on Alphastreet.
Priority Technology Holdings, Inc (NASDAQ:PRTH) reported fourth quarter 2025 financial results. Q4 2025 adjusted earnings at Priority Technology Holdings, ...
The post Priority Technology Holdings, Inc (PRTH) Reports Q4 Earnings first appeared on Alphastreet.
Nio Inc (NIO) delivered Q4 2025 gaap earnings of $0.29 per share, surpassing analysts' $0.05 forecast (beat by 441.4%). Top-line revenue was $4.61B. The Ch...
The post Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin first appeared on Alphastreet.
**BREAKING: Prelude Therapeutics Reports Wider-Than-Expected Q4 Loss**
The post Prelude Therapeutics Inc (PRLD) Reports Wider Loss for FY25 vs. Estimates first appeared on Alphastreet.
**Cullinan Therapeutics Inc Reports Q4 2025 Results**
The post Cullinan Therapeutics Inc (CGEM) Reports Q4 Earnings first appeared on Alphastreet.
Apyx Medical narrows Q4 loss to $0.06 per share as revenue surges 34.8% year-over-year to $19.2 million, with fiscal 2026 guidance of $57.5-$58.5 million.
The post Apyx Medical (APYX) Q4 Revenue Jumps 34.8% to $19.2M, Loss Narrows to $0.06/Share first appeared on Alphastreet.
**BREAKING: Opus Genetics Inc. Reports Q4 2025 Results**
The post Opus Genetics Inc. (IRD) Reports FY25 Earnings first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
